RxDoctor Payments Data

William Wagner, DO

Family Medicine · Walla Walla, WANPI 1871567941

Payments from drug & device makers

$1,029in general payments, 2019–2025

Across 53 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$268
  • Bayer$115
  • AstraZeneca$108
  • Pfizer$87
  • Sanofi Pasteur Inc.$85
  • Astellas Pharma US Inc$55
  • plus $310 from 13 others

What the payments were for

  • Food & beverage$1,029100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,029 in reported general payments places this provider in the 80th percentile of 2,275 family medicine providers in Washington.

See all family medicine providers in Washington

Medicare billing

Part B allowed, 2024
$13,535
Medicare patients
112
Services billed
288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban75$44,442
XareltoRivaroxaban18$26,530
JardianceEmpagliflozin25$21,167
OzempicSemaglutide20$17,817
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr31$16,479
LinzessLinaclotide30$16,308
JanuviaSitagliptin Phosphate20$14,788
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog26$12,305
FarxigaDapagliflozin Propanediol13$8,325
Breo ElliptaFluticasone/Vilanterol13$6,998
SymbicortBudesonide/Formoterol Fumarate26$6,113
Fluticasone-SalmeterolFluticasone Propion/Salmeterol72$5,761
DuleraMometasone/Formoterol11$5,605
Albuterol Sulfate HfaAlbuterol Sulfate159$5,226
BelsomraSuvorexant12$5,070

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$87$44,44275 claims
Boehringer IngelheimJardiance, Tradjenta$29$25,67336 claims
AbbVieLinzess$268$16,30830 claims
AstraZenecaFarxiga, Symbicort$108$14,43739 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,275 family medicine providers in Washington.

Other family medicine in Walla Walla

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →